Compare BioNano Genomics Inc (BNGO) vs ArcelorMittal SA (MT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs ArcelorMittal SA — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.66M), while ArcelorMittal SA trades at $74.2 (market cap $55.88B). The key difference: ArcelorMittal SA is far larger — about 4090.8× BioNano Genomics Inc's market cap, and ArcelorMittal SA pays a 0.81% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | MT | |
|---|---|---|
Market Cap | $13.66M | $55.88B |
Sector | Health | Basic Materials |
52-Week High | $4.92 | $75.35 |
52-Week Low | $1.06 | $32.44 |
Enterprise Value | $16.26M | $65.45B |
Dividend Yield | — | 0.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About ArcelorMittal SA
ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →
